| |
 |
|
|
Inventor: Clark; Robin Douglas
Address: Lawai, HI
No. of patents: 8
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 7223767 |
Tetrahydroquinazolines and dihydrocyclopentapyrimidines as CRF antagonists |
May 29, 2007 |
| Compounds of the formula (I): ##STR00001## and pharmaceutically acceptable salts or prodrugs thereof, wherein m, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are as defined herein. The invention also provides methods for preparing, compositions comprising, and methods for |
| 7202241 |
Benzoxazine derivatives and uses thereof |
April 10, 2007 |
| Compounds of the formula (I): ##STR00001## or pharmaceutically acceptable salts, solvates or prodrugs thereof, where R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, X, Y and m are as defined herein. Also provided are compositions comprising, methods for |
| 7135476 |
Spiro tetrahydroquinazolines and dihydrocyclopentapyrimidines as CRF antagonists |
November 14, 2006 |
| Compounds of the formula (I): ##STR00001## and pharmaceutically acceptable salts or prodrugs thereof, wherein m, n, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, and R.sup.9 are as defined herein. The invention also provides methods for preparing, compositi |
| 7078401 |
Thiophenylaminoimidazolines as IP antagonists |
July 18, 2006 |
| Methods for treatment of IP antagonist mediated diseases or conditions by administration to a subject in need thereof a compound of formula (I) ##STR00001## wherein R.sup.1, R.sup.2, A and X are as defined herein. Also disclosed are compounds and related compositions. |
| 7022708 |
4-piperazinyl benzenesulfonyl indoles and uses thereof |
April 4, 2006 |
| This invention relates to compounds which have generally 5-HT6 receptor affinity and which are represented by Formula I: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, and R.sup.5 are as defined herein; or individual isomers, racemic or non-racemic mixtures of isomers, or |
| 6867204 |
Benzoxazine derivatives and uses thereof |
March 15, 2005 |
| Compounds of the formula: ##STR1##or pharmaceutically acceptable salts or prodrugs thereof, where each of n and p independently is 2 or 3, Y is --SO.sub.2 -- or --SO.sub.2 --N(R.sup.10)--, Z.sup.1 is CH or N, and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, |
| 6825202 |
Arylsulfonyl derivatives with 5-HT6 receptor affinity |
November 30, 2004 |
| This invention relates to compounds which have generally 5-HT6 receptor affinity and which are represented by Formula (I): ##STR1##wherein Ar, R.sup.1, R.sup.2, R.sup.3 or R.sup.4 are as defined in the specification, or pharmaceutically acceptable salts or solvates thereof. The inven |
| 6774241 |
1-sulfonyl-4-aminoalkoxy indole derivatives and uses thereof |
August 10, 2004 |
| The present invention provides a compound of the formula: ##STR1##a pharmaceutically acceptable salt or a prodrug thereof, where R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, and n are as defined herein. The present invention also provides compositions comprising, methods for |
|
|
|
